CYP 1.82% 28.0¢ cynata therapeutics limited

The cells were stamped fit for human trial over 3 years ago....

  1. 174 Posts.
    lightbulb Created with Sketch. 85
    The cells were stamped fit for human trial over 3 years ago. They have now been proven somewhat safe to advance to phase 2. Anyone could have done a phase 1 with them over the last 3 years, probably quite cheaply too, and they still will, if they modify or change the admin route. 
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.